查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1617793

体外毒理学测试市场：按技术、方法、应用、最终用户产业划分 - 2025-2030 年全球预测

In-Vitro Toxicology Testing Market by Technology (Cell Culture Technology, High Throughput Technology, Molecular Imaging), Method (Biochemical Assay, Cellular Assay, Ex-vivo), Application, End-User Industry - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年体外毒理学测试市场价值为122.1亿美元，预计到2024年将达到134.9亿美元，复合年增长率为10.90%，到2030年将达到252.1亿美元。

体外毒性测试研究化学物质对培养细菌或哺乳动物细胞的毒性作用。它提供了传统体内测试的重要替代方案，并减少了与动物测试相关的伦理问题和成本。这项需求源自于监管要求，旨在解决消费品安全和环境问题，并强调上市前的安全性。应用范围广泛，包括製药、化妆品、农业化学品和化学工业。最终用途包括研究机构、诊断实验室和监管机构。市场成长是由高通量筛检、对非动物测试方法的监管支持增加以及对药物安全性评估的需求增加等技术进步所推动的。潜在的商机植根于开发更具预测性的体外模型和个人化毒性测试，以满足精准医疗的需求。新兴经济体研发设施投资的增加也开启了重要的市场开拓。

主要市场统计
基准年[2023] 122.1亿美元
预计年份 [2024] 134.9亿美元
预测年份 [2030] 252.1亿美元
复合年增长率（%） 10.90%

然而，挑战包括体外和体内结果之间的相关性差、细胞模型多样性的丧失以及阻碍小规模实施的初始设置成本高。此外，抵制变革和接受新测试方法可能会减慢市场渗透率。创新领域包括整合人工智慧和预测分析以提高测试效率，以及使用先进的细胞培养模型（例如3D培养和晶片上器官技术）来更接近模仿人类生物系统。市场的特点是技术发展迅速、竞争激烈，需要不断的技术创新。公司还必须透过严格的验证流程来应对复杂的监管环境，同时支援非动物测试。因此，促进与监管机构的合作并投资于提高与人类生物学相关性的技术对于持续成长和市场领导至关重要。关注道德标准和透明度可以增加公众信任并进一步促进市场扩张。

市场动态：揭示快速发展的体外毒理学测试市场的关键市场洞察

供需的动态交互作用正在改变体外毒性测试市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 药物发现和新农业化学品和食品添加剂推出的研发倡议
    • 体外毒性试验在医疗设备评估的应用
  • 市场限制因素
    • 技术限制和无法准确再现某些生物现象
  • 市场机会
    • 体外毒性测试的进展以及采用计算生物学进行毒理学资料分析
    • 旨在促进无残忍测试和开发新的毒性测试方法的政府计划
  • 市场挑战
    • 目前模式下药品核准失败的可能性

波特五力：驾驭体外毒理学测试市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解体外毒理学测试市场的外部影响

外部宏观环境因素在塑造体外毒理学测试市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解体外毒性测试市场的竞争状况

体外毒理学测试市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵体外毒性测试市场供应商的绩效评估

FPNV定位矩阵是评估体外毒性测试市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製体外毒理学测试市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，体外毒理学测试市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 旨在新农业化学品和食品添加剂的药物发现和商业化的研究和开发工作
      • 体外毒性试验在医疗设备评估的应用
    • 抑制因素
      • 技术限制和无法准确再现某些生物现象
    • 机会
      • 体外毒性测试的进展以及计算生物学在毒性资料分析中的应用
      • 政府计划推广无残忍测试方法并开发新的毒性测试方法
    • 任务
      • 在当前模式下，药物核准可能会失败。
  • 市场区隔分析
    • 技术：体外毒性测试技术的选择很大程度上取决于特定的研究需求。
    • 方法：细胞测定在毒性、药物动力学和动态的体外毒性测试中变得越来越重要。
    • 应用：人们越来越关注改进测试方法，同时提供准确可靠的结果，同时满足特定产业的要求。
    • 最终用途：积极使用体外测试来确保食品和製药领域的安全标准
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章体外毒理学测试市场：依技术分类

  • 细胞培养技术
  • 高通量技术
  • 分子影像
  • 体学技术

第七章体外毒理学测试市场：依方法分类

  • 生化分析
  • 细胞测定
  • 体外
  • 模拟

第八章体外毒理学测试市场：依应用分类

  • 经皮毒性
  • 内分泌干扰
  • 眼毒性
  • 系统毒理学

第 9 章 体外毒理学测试市场：按最终用户产业

  • 化学品
  • 化妆品/家居用品
  • 食物
  • 药品和生物製药

第十章 北美、南美洲体外毒性测试市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太体外毒理学测试市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东、非洲体外毒性测试市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • LGC 临床诊断公司收购 QC 产品製造商 Kova International
    • ERBC 集团透过收购 Oncofactory 扩大临床前专业知识
    • IIVS 和 Toxys 签署协议，提供 ToxTracker 用于体外遗传毒性评估
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • BioIVT LLC
  • Charles River Laboratories International, Inc.
  • Creative Bioarray
  • ERBC Group
  • Eurofins Scientific SE
  • Evotec SE
  • F. Hoffmann-La Roche AG
  • Gentronix Limited
  • HD Biosciences Co., Ltd.
  • INDIGO Biosciences, Inc.
  • Inotiv, Inc.
  • InSphero AG
  • Intertek Group PLC
  • Laboratory Corporation of America Holdings
  • LAUS GmbH
  • LGC Limited
  • Merck KGaA
  • Microbac Laboratories Inc.
  • Oroxcell SAS
  • Promega Corporation
  • Qiagen NV
  • SGS SA
  • Thermo Fisher Scientific Inc.
  • Toxys, Inc.
  • Vimta Labs Ltd.
  • WuXi AppTec
Product Code: MRR-A339DAEFAF18

The In-Vitro Toxicology Testing Market was valued at USD 12.21 billion in 2023, expected to reach USD 13.49 billion in 2024, and is projected to grow at a CAGR of 10.90%, to USD 25.21 billion by 2030.

In-vitro toxicology testing involves the study of toxic effects of chemical substances on cultured bacteria or mammalian cells. It offers a critical alternative to traditional in-vivo testing, reducing ethical concerns and costs associated with animal testing. Necessity stems from regulatory mandates emphasizing safety before market entry, addressing both consumer product safety and environmental considerations. Applications are widespread, spanning pharmaceuticals, cosmetics, agrochemicals, and chemical industries. End-use extends to research institutions, diagnostic laboratories, and regulatory bodies. Market growth is driven by technological advancements such as high-throughput screening, increasing regulatory support for non-animal testing methods, and the rising need for drug safety assessment. Potential opportunities are rooted in the development of more predictive in-vitro models and personalized toxicology testing, capitalizing on the demand for precision medicine. Increasing investment in developing economies for R&D facilities also opens significant market avenues.

KEY MARKET STATISTICS
Base Year [2023] USD 12.21 billion
Estimated Year [2024] USD 13.49 billion
Forecast Year [2030] USD 25.21 billion
CAGR (%) 10.90%

However, challenges include limited correlation between in-vitro and in-vivo results, diversity loss in cellular models, and high initial setup costs hindering small-scale adoption. Furthermore, resistance to change and acceptance of novel testing methods can slow market penetration. Innovative areas focus on the integration of artificial intelligence with predictive analytics to enhance testing efficacy, and the development of advanced cell culture models like 3D cultures and organ-on-a-chip technology to mimic human biological systems closely. The market is characterized by rapid technological evolution and competitive intensity, necessitating continuous innovation. Companies must also navigate the complex regulatory landscape which, while supporting non-animal methods, involves rigorous validation processes. Thus, fostering collaborations with regulatory bodies and investing in technologies that enhance relevance to human biology will be pivotal for sustained growth and market leadership. Emphasizing ethical standards and transparency could bolster public trust, further catalyzing market expansion.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving In-Vitro Toxicology Testing Market

The In-Vitro Toxicology Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • R&D initiatives for drug discovery and launch of novel agrochemicals and food additives
    • Utilization of in-vitro toxicology testing for evaluation of medical devices
  • Market Restraints
    • Technical limitations and inability to accurately replicate certain biological phenomena
  • Market Opportunities
    • Advancements in in-vitro toxicology testing and adoption of computational biology for analyzing toxicology data
    • Government programs to promote cruelty-free testing methods and develop novel toxicology assays
  • Market Challenges
    • Chances of drug approval failures with the current models.

Porter's Five Forces: A Strategic Tool for Navigating the In-Vitro Toxicology Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the In-Vitro Toxicology Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the In-Vitro Toxicology Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the In-Vitro Toxicology Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the In-Vitro Toxicology Testing Market

A detailed market share analysis in the In-Vitro Toxicology Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the In-Vitro Toxicology Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the In-Vitro Toxicology Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the In-Vitro Toxicology Testing Market

A strategic analysis of the In-Vitro Toxicology Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the In-Vitro Toxicology Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BioIVT LLC, Charles River Laboratories International, Inc., Creative Bioarray, ERBC Group, Eurofins Scientific SE, Evotec SE, F. Hoffmann-La Roche AG, Gentronix Limited, HD Biosciences Co., Ltd., INDIGO Biosciences, Inc., Inotiv, Inc., InSphero AG, Intertek Group PLC, Laboratory Corporation of America Holdings, LAUS GmbH, LGC Limited, Merck KGaA, Microbac Laboratories Inc., Oroxcell SAS, Promega Corporation, Qiagen N.V., SGS SA, Thermo Fisher Scientific Inc., Toxys, Inc., Vimta Labs Ltd., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the In-Vitro Toxicology Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Cell Culture Technology, High Throughput Technology, Molecular Imaging, and OMICS Technology.
  • Based on Method, market is studied across Biochemical Assay, Cellular Assay, Ex-vivo, and In Silico.
  • Based on Application, market is studied across Dermal Toxicity, Endocrine Disruption, Occular Toxicity, and Systemic Toxicology.
  • Based on End-User Industry, market is studied across Chemicals, Cosmetic & Household Products, Food, and Pharmaceuticals & Biopharmaceuticals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. R&D initiatives for drug discovery and launch of novel agrochemicals and food additives
      • 5.1.1.2. Utilization of in-vitro toxicology testing for evaluation of medical devices
    • 5.1.2. Restraints
      • 5.1.2.1. Technical limitations and inability to accurately replicate certain biological phenomena
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in in-vitro toxicology testing and adoption of computational biology for analyzing toxicology data
      • 5.1.3.2. Government programs to promote cruelty-free testing methods and develop novel toxicology assays
    • 5.1.4. Challenges
      • 5.1.4.1. Chances of drug approval failures with the current models.
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Preference for in-vitro toxicology testing technology selection largely depends by specific research needs
    • 5.2.2. Method: Cellular assays gained importance in toxicity, pharmacokinetics and pharmacodynamics in vitro toxicology testing
    • 5.2.3. Application: Rising focus on improving testing methods while delivering accurate, reliable results catering to industry-specific requirements
    • 5.2.4. End-Use: In vitro testing used vigorously in food and pharma sectors to ensure safety standards
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. In-Vitro Toxicology Testing Market, by Technology

  • 6.1. Introduction
  • 6.2. Cell Culture Technology
  • 6.3. High Throughput Technology
  • 6.4. Molecular Imaging
  • 6.5. OMICS Technology

7. In-Vitro Toxicology Testing Market, by Method

  • 7.1. Introduction
  • 7.2. Biochemical Assay
  • 7.3. Cellular Assay
  • 7.4. Ex-vivo
  • 7.5. In Silico

8. In-Vitro Toxicology Testing Market, by Application

  • 8.1. Introduction
  • 8.2. Dermal Toxicity
  • 8.3. Endocrine Disruption
  • 8.4. Occular Toxicity
  • 8.5. Systemic Toxicology

9. In-Vitro Toxicology Testing Market, by End-User Industry

  • 9.1. Introduction
  • 9.2. Chemicals
  • 9.3. Cosmetic & Household Products
  • 9.4. Food
  • 9.5. Pharmaceuticals & Biopharmaceuticals

10. Americas In-Vitro Toxicology Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific In-Vitro Toxicology Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa In-Vitro Toxicology Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. LGC Clinical Diagnostics Acquires QC Product Maker Kova International
    • 13.3.2. ERBC Group Extends its Preclinical Expertise with the Acquisition of Oncofactory
    • 13.3.3. IIVS and Toxys Entered into an Agreement to Offer ToxTracker for In-Vitro Genetic Toxicity Evaluation
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agilent Technologies, Inc.
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Bio-Techne Corporation
  • 6. BioIVT LLC
  • 7. Charles River Laboratories International, Inc.
  • 8. Creative Bioarray
  • 9. ERBC Group
  • 10. Eurofins Scientific SE
  • 11. Evotec SE
  • 12. F. Hoffmann-La Roche AG
  • 13. Gentronix Limited
  • 14. HD Biosciences Co., Ltd.
  • 15. INDIGO Biosciences, Inc.
  • 16. Inotiv, Inc.
  • 17. InSphero AG
  • 18. Intertek Group PLC
  • 19. Laboratory Corporation of America Holdings
  • 20. LAUS GmbH
  • 21. LGC Limited
  • 22. Merck KGaA
  • 23. Microbac Laboratories Inc.
  • 24. Oroxcell SAS
  • 25. Promega Corporation
  • 26. Qiagen N.V.
  • 27. SGS SA
  • 28. Thermo Fisher Scientific Inc.
  • 29. Toxys, Inc.
  • 30. Vimta Labs Ltd.
  • 31. WuXi AppTec

LIST OF FIGURES

  • FIGURE 1. IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. IN-VITRO TOXICOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. IN-VITRO TOXICOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IN-VITRO TOXICOLOGY TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IN-VITRO TOXICOLOGY TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY OMICS TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY BIOCHEMICAL ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELLULAR ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY EX-VIVO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY IN SILICO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DERMAL TOXICITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY ENDOCRINE DISRUPTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY OCCULAR TOXICITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SYSTEMIC TOXICOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CHEMICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETIC & HOUSEHOLD PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY FOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMACEUTICALS & BIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 195. IN-VITRO TOXICOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 196. IN-VITRO TOXICOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2023